Sat Kartar Shopping Limited is an Ayurveda healthcare company that delivers natural wellness solutions for therapeutic and lifestyle products.Business Model The company operates in the Ayurveda healthcare sector using a Direct-to-Consumer (D2C) model, combining Ayurvedic principles with modern research. It focuses on product innovation, branding, and marketing while outsourcing manufacturing...
Sat Kartar Life confirms it does not qualify as a 'Large Corporate', reducing specific compliance requirements for debt financing. The company reports outstanding borrowings of Rs 2.39 Cr, indicating its current debt position.
Sat Kartar Life acquired an additional 24% stake in Plantomed Nutraceuticals for 1.21 Cr, making it a wholly-owned subsidiary. This secures 100% control, aiming for brand consolidation and product expansion in the Ayurveda healthcare sector.
Sat Kartar Life plans a ~₹48.59 Cr fundraise through preferential issue of equity shares and convertible warrants to boost its integrated healthcare platform. Separately, it will acquire the remaining 24% of Plantomed Neutraceuticals for ₹1.21 Cr, making it a wholly-owned subsidiary for product and brand growth.
Sat Kartar Life partnered with Jeena Sikho Lifecare to integrate its tech-driven patient engagement with JSLL's institutional Ayurveda hospitals. This collaboration aims to boost efficiency, scalability, and patient outcomes. SKL will also develop hospitals, with JSLL providing operational management.
Sat Kartar Life, listed on NSE (SME), confirms it's exempt from filing a specific annual secretarial compliance report. This clarifies its reduced reporting obligations as an SME entity, streamlining administrative requirements.
